Clinical Trials Directory

Trials / Completed

CompletedNCT05859152

Zona Pellucida Bound Sperm vs. Embryologist Selected Sperm for Intracytoplasmic Sperm Injection

Comparing the Outcomes of Intracytoplasmic Sperm Injection (ICSI) Using the Zona Pellucida-Bound Sperm Versus Conventional Manually Selected Sperm

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
IVI America · Academic / Other
Sex
All
Age
18 Years – 41 Years
Healthy volunteers
Not accepted

Summary

This study aims to assess the clinical significance of the intracytoplasmic sperm injection (ICSI) with zona-pellucida (ZP) bound sperm compared to ICSI with embryologist selected sperm for patients undergoing in vitro fertilization treatment of their infertility.

Detailed description

In this study, the investigators aim to determine the clinical utility of the ZP-bound sperm selection methodology for ICSI. This study will be a prospective, split cohort, randomized, control trial comparing the routine standard of sperm selection for ICSI via the embryologist versus sperm selected via ZP-binding for ICSI. Embryology, ploidy and clinical pregnancy outcomes will be assessed.

Conditions

Interventions

TypeNameDescription
OTHERZona Pellucida-Bound Sperm Selection for ICSIone half of the patients' oocytes will be inseminated via the ICSI procedure with sperm that was bound to the ZP of an immature oocyte.
OTHERRoutine Embryologist Selected Spermone half of the patients' oocytes will be inseminated via the ICSI procedure with sperm that has been selected based on morphology and mobility characteristics by the embryologist per routine.

Timeline

Start date
2023-11-03
Primary completion
2024-12-02
Completion
2025-09-14
First posted
2023-05-15
Last updated
2026-01-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05859152. Inclusion in this directory is not an endorsement.